CNBC
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
EconomyDaily Composite
Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
C
Source
CNBC
Read full article at CNBC
Opens original article in a new tab
Advertisement
